The role of obesity, insulin resistance and fatty liver (steatosis) in human disease and strategies to monitor and improve patient outcomes

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

The overall objective of my research activity is to examine in human subjects, the mechanisms by which obesity and fatty liver impair the response of the liver to injury and inflammation from multiple causes and to develop specific strategies to monitor and improve the outcome of treatment in overweight patients with liver disease.

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2015

Funding Scheme: Practitioner Fellowship

Funding Amount: $322,892.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical and Health Sciences not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

fatty liver disease | fibrosis | hepatitis C infection | hepatitis C virus | lifestyle factors | liver | metabolic syndrome